anmelden
FTSE All-Share
5.539,85
PKT
+30,20
PKT
+0,55
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 05.05.16 | Imperial Brands buy | Société Générale Group S.A. (SG) | |
| 05.05.16 | AstraZeneca buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 04.05.16 | HSBC Underweight | Morgan Stanley | |
| 04.05.16 | AstraZeneca Hold | HSBC | |
| 04.05.16 | Diageo Hold | HSBC | |
| 04.05.16 | HSBC Neutral | Goldman Sachs Group Inc. | |
| 04.05.16 | HSBC Hold | Deutsche Bank AG | |
| 04.05.16 | GSK overweight | Barclays Capital | |
| 03.05.16 | Lloyds Banking Group Halten | Independent Research GmbH | |
| 03.05.16 | BT Group Neutral | Citigroup Corp. | |
| 03.05.16 | HSBC buy | Citigroup Corp. | |
| 03.05.16 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 03.05.16 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 02.05.16 | BAT Halten | Independent Research GmbH | |
| 29.04.16 | Lloyds Banking Group overweight | JP Morgan Chase & Co. | |
| 29.04.16 | Imperial Brands buy | Citigroup Corp. | |
| 29.04.16 | Barclays buy | UBS AG | |
| 29.04.16 | BT Group Neutral | UBS AG | |
| 29.04.16 | Lloyds Banking Group buy | UBS AG | |
| 28.04.16 | GSK neutral | Independent Research GmbH | |
| 28.04.16 | Barclays buy | Citigroup Corp. | |
| 28.04.16 | BT Group Equal-Weight | Morgan Stanley | |
| 28.04.16 | GSK Equal-Weight | Morgan Stanley | |
| 28.04.16 | Diageo overweight | Morgan Stanley | |
| 28.04.16 | Barclays Equal-Weight | Morgan Stanley | |
| 28.04.16 | Barclays overweight | JP Morgan Chase & Co. | |
| 28.04.16 | GSK Neutral | JP Morgan Chase & Co. | |
| 28.04.16 | Diageo overweight | JP Morgan Chase & Co. | |
| 28.04.16 | BP buy | Deutsche Bank AG | |
| 28.04.16 | GSK Hold | Deutsche Bank AG | |
| 28.04.16 | Barclays Hold | Deutsche Bank AG | |
| 28.04.16 | Lloyds Banking Group buy | UBS AG | |
| 28.04.16 | GSK buy | HSBC | |
| 28.04.16 | Barclays Conviction Buy List | Goldman Sachs Group Inc. | |
| 28.04.16 | GSK Neutral | UBS AG | |
| 28.04.16 | GSK Sell | Société Générale Group S.A. (SG) | |
| 27.04.16 | BP Halten | Independent Research GmbH | |
| 27.04.16 | BAT Underperform | Robert W. Baird & Co. Incorporated | |
| 27.04.16 | Unilever Outperform | Robert W. Baird & Co. Incorporated | |
| 27.04.16 | Unilever Outperform | Robert W. Baird & Co. Incorporated |